ICAM1 and diabetic kidney disease: In our research, serum and urinary levels of ICAM-1 were increased and correlated with biomarkers of podocyte damage and PT dysfunction, in all patient groups, thus emphasizing the intervention of this adhesion molecule in early DKD.